GH1 and cancer: Long-term CR is reported to reduce IGF-1 serum levels in rodents by ~30–40%, protecting them against several types of cancers, while treatments with GH or IGF-1 can reverse this protective effect mediated by CR, confirming the important role of these factors in cancer pathogenesis [84,85,86,87].